APO RESEARCH · REPORT
Melatonin
Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.
Product & engineering
Understand the product.
Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.
Selected research
Market Analysis & Forecast
Global Melatonin Market Analysis and Forecast 2026-2032
Market perspective
Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.
Neurim Pharma, Natrol, Pharmavite, Nature's Bounty and Jameison are the leaders of the Melatonin industry, which take about 30% market share. North America and Europe are the major region of the global market, which takes about 70% market share.
Report Includes
Read the full market overview
This report presents an overview of global market for Melatonin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Melatonin, also provides the revenue of main regions and countries. Of the upcoming market potential for Melatonin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Melatonin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Melatonin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Melatonin revenue, projected growth trends, production technology, application and end-user industry.
Melatonin Segment by Company
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
By-Health
Pfizer
Solgar
Biotics Research
Now Food
Melatonin Segment by Type
Pharmaceutical Grade Melatonin
Food Grade Melatonin
Melatonin Segment by Application
Dietary Supplements
Medical
Others
Melatonin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melatonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Melatonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melatonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Melatonin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Melatonin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melatonin revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Grade Melatonin
- Food Grade Melatonin
Applications
- Dietary Supplements
- Medical
- Others
Companies covered
- Natrol
- Pharmavite
- Nature's Bounty
- Jameison
- Rexall Sundown
- GNC
- Xiu Zheng
- Church & Dwight
- By-Health
- Pfizer
- Solgar
- Biotics Research
- Now Food
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Melatonin Market by Type
- 1.2.1 Global Melatonin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pharmaceutical Grade Melatonin
- 1.2.3 Food Grade Melatonin
- 1.3 Melatonin Market by Application
- 1.3.1 Global Melatonin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Dietary Supplements
- 1.3.3 Medical
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Melatonin Market Dynamics
- 2.1 Melatonin Industry Trends
- 2.2 Melatonin Industry Drivers
- 2.3 Melatonin Industry Opportunities and Challenges
- 2.4 Melatonin Industry Restraints
3 Global Growth Perspective
- 3.1 Global Melatonin Market Perspective (2021-2032)
- 3.2 Global Melatonin Growth Trends by Region
- 3.2.1 Global Melatonin Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Melatonin Market Size by Region (2021-2026)
- 3.2.3 Global Melatonin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Melatonin Revenue by Players
- 4.1.1 Global Melatonin Revenue by Players (2021-2026)
- 4.1.2 Global Melatonin Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Melatonin Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Melatonin Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Melatonin Key Players Headquarters & Area Served
- 4.4 Global Melatonin Players, Product Type & Application
- 4.5 Global Melatonin Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Melatonin Market CR5 and HHI
- 4.6.3 2025 Melatonin Tier 1, Tier 2, and Tier 3
5 Melatonin Market Size by Type
- 5.1 Global Melatonin Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Melatonin Revenue by Type (2021-2032)
- 5.3 Global Melatonin Revenue Market Share by Type (2021-2032)
6 Melatonin Market Size by Application
- 6.1 Global Melatonin Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Melatonin Revenue by Application (2021-2032)
- 6.3 Global Melatonin Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Natrol
- 7.1.1 Natrol Company Information
- 7.1.2 Natrol Business Overview
- 7.1.3 Natrol Melatonin Revenue and Gross Margin (2021-2026)
- 7.1.4 Natrol Melatonin Product Portfolio
- 7.1.5 Natrol Recent Developments
- 7.2 Pharmavite
- 7.2.1 Pharmavite Company Information
- 7.2.2 Pharmavite Business Overview
- 7.2.3 Pharmavite Melatonin Revenue and Gross Margin (2021-2026)
- 7.2.4 Pharmavite Melatonin Product Portfolio
- 7.2.5 Pharmavite Recent Developments
- 7.3 Nature's Bounty
- 7.3.1 Nature's Bounty Company Information
- 7.3.2 Nature's Bounty Business Overview
- 7.3.3 Nature's Bounty Melatonin Revenue and Gross Margin (2021-2026)
- 7.3.4 Nature's Bounty Melatonin Product Portfolio
- 7.3.5 Nature's Bounty Recent Developments
- 7.4 Jameison
- 7.4.1 Jameison Company Information
- 7.4.2 Jameison Business Overview
- 7.4.3 Jameison Melatonin Revenue and Gross Margin (2021-2026)
- 7.4.4 Jameison Melatonin Product Portfolio
- 7.4.5 Jameison Recent Developments
- 7.5 Rexall Sundown
- 7.5.1 Rexall Sundown Company Information
- 7.5.2 Rexall Sundown Business Overview
- 7.5.3 Rexall Sundown Melatonin Revenue and Gross Margin (2021-2026)
- 7.5.4 Rexall Sundown Melatonin Product Portfolio
- 7.5.5 Rexall Sundown Recent Developments
- 7.6 GNC
- 7.6.1 GNC Company Information
- 7.6.2 GNC Business Overview
- 7.6.3 GNC Melatonin Revenue and Gross Margin (2021-2026)
- 7.6.4 GNC Melatonin Product Portfolio
- 7.6.5 GNC Recent Developments
- 7.7 Xiu Zheng
- 7.7.1 Xiu Zheng Company Information
- 7.7.2 Xiu Zheng Business Overview
- 7.7.3 Xiu Zheng Melatonin Revenue and Gross Margin (2021-2026)
- 7.7.4 Xiu Zheng Melatonin Product Portfolio
- 7.7.5 Xiu Zheng Recent Developments
- 7.8 Church & Dwight
- 7.8.1 Church & Dwight Company Information
- 7.8.2 Church & Dwight Business Overview
- 7.8.3 Church & Dwight Melatonin Revenue and Gross Margin (2021-2026)
- 7.8.4 Church & Dwight Melatonin Product Portfolio
- 7.8.5 Church & Dwight Recent Developments
- 7.9 By-Health
- 7.9.1 By-Health Company Information
- 7.9.2 By-Health Business Overview
- 7.9.3 By-Health Melatonin Revenue and Gross Margin (2021-2026)
- 7.9.4 By-Health Melatonin Product Portfolio
- 7.9.5 By-Health Recent Developments
- 7.10 Pfizer
- 7.10.1 Pfizer Company Information
- 7.10.2 Pfizer Business Overview
- 7.10.3 Pfizer Melatonin Revenue and Gross Margin (2021-2026)
- 7.10.4 Pfizer Melatonin Product Portfolio
- 7.10.5 Pfizer Recent Developments
- 7.11 Solgar
- 7.11.1 Solgar Company Information
- 7.11.2 Solgar Business Overview
- 7.11.3 Solgar Melatonin Revenue and Gross Margin (2021-2026)
- 7.11.4 Solgar Melatonin Product Portfolio
- 7.11.5 Solgar Recent Developments
- 7.12 Biotics Research
- 7.12.1 Biotics Research Company Information
- 7.12.2 Biotics Research Business Overview
- 7.12.3 Biotics Research Melatonin Revenue and Gross Margin (2021-2026)
- 7.12.4 Biotics Research Melatonin Product Portfolio
- 7.12.5 Biotics Research Recent Developments
- 7.13 Now Food
- 7.13.1 Now Food Company Information
- 7.13.2 Now Food Business Overview
- 7.13.3 Now Food Melatonin Revenue and Gross Margin (2021-2026)
- 7.13.4 Now Food Melatonin Product Portfolio
- 7.13.5 Now Food Recent Developments
8 North America
- 8.1 North America Melatonin Revenue (2021-2032)
- 8.2 North America Melatonin Revenue by Type (2021-2032)
- 8.2.1 North America Melatonin Revenue by Type (2021-2026)
- 8.2.2 North America Melatonin Revenue by Type (2027-2032)
- 8.3 North America Melatonin Revenue Share by Type (2021-2032)
- 8.4 North America Melatonin Revenue by Application (2021-2032)
- 8.4.1 North America Melatonin Revenue by Application (2021-2026)
- 8.4.2 North America Melatonin Revenue by Application (2027-2032)
- 8.5 North America Melatonin Revenue Share by Application (2021-2032)
- 8.6 North America Melatonin Revenue by Country
- 8.6.1 North America Melatonin Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Melatonin Revenue by Country (2021-2026)
- 8.6.3 North America Melatonin Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Melatonin Revenue (2021-2032)
- 9.2 Europe Melatonin Revenue by Type (2021-2032)
- 9.2.1 Europe Melatonin Revenue by Type (2021-2026)
- 9.2.2 Europe Melatonin Revenue by Type (2027-2032)
- 9.3 Europe Melatonin Revenue Share by Type (2021-2032)
- 9.4 Europe Melatonin Revenue by Application (2021-2032)
- 9.4.1 Europe Melatonin Revenue by Application (2021-2026)
- 9.4.2 Europe Melatonin Revenue by Application (2027-2032)
- 9.5 Europe Melatonin Revenue Share by Application (2021-2032)
- 9.6 Europe Melatonin Revenue by Country
- 9.6.1 Europe Melatonin Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Melatonin Revenue by Country (2021-2026)
- 9.6.3 Europe Melatonin Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Melatonin Revenue (2021-2032)
- 10.2 China Melatonin Revenue by Type (2021-2032)
- 10.2.1 China Melatonin Revenue by Type (2021-2026)
- 10.2.2 China Melatonin Revenue by Type (2027-2032)
- 10.3 China Melatonin Revenue Share by Type (2021-2032)
- 10.4 China Melatonin Revenue by Application (2021-2032)
- 10.4.1 China Melatonin Revenue by Application (2021-2026)
- 10.4.2 China Melatonin Revenue by Application (2027-2032)
- 10.5 China Melatonin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Melatonin Revenue (2021-2032)
- 11.2 Asia Melatonin Revenue by Type (2021-2032)
- 11.2.1 Asia Melatonin Revenue by Type (2021-2026)
- 11.2.2 Asia Melatonin Revenue by Type (2027-2032)
- 11.3 Asia Melatonin Revenue Share by Type (2021-2032)
- 11.4 Asia Melatonin Revenue by Application (2021-2032)
- 11.4.1 Asia Melatonin Revenue by Application (2021-2026)
- 11.4.2 Asia Melatonin Revenue by Application (2027-2032)
- 11.5 Asia Melatonin Revenue Share by Application (2021-2032)
- 11.6 Asia Melatonin Revenue by Country
- 11.6.1 Asia Melatonin Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Melatonin Revenue by Country (2021-2026)
- 11.6.3 Asia Melatonin Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Melatonin Revenue (2021-2032)
- 12.2 SAMEA Melatonin Revenue by Type (2021-2032)
- 12.2.1 SAMEA Melatonin Revenue by Type (2021-2026)
- 12.2.2 SAMEA Melatonin Revenue by Type (2027-2032)
- 12.3 SAMEA Melatonin Revenue Share by Type (2021-2032)
- 12.4 SAMEA Melatonin Revenue by Application (2021-2032)
- 12.4.1 SAMEA Melatonin Revenue by Application (2021-2026)
- 12.4.2 SAMEA Melatonin Revenue by Application (2027-2032)
- 12.5 SAMEA Melatonin Revenue Share by Application (2021-2032)
- 12.6 SAMEA Melatonin Revenue by Country
- 12.6.1 SAMEA Melatonin Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Melatonin Revenue by Country (2021-2026)
- 12.6.3 SAMEA Melatonin Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst